Table 2.
Baseline clinical data (n, %).
| Control group (N = 316) | Treatment group (N = 324) |
P | |
|---|---|---|---|
| Age () | 59.67 ± 9.33 | 60.91 ± 8.97 | 0.09 |
| Gender | |||
| Male | 249 (78.8) | 250 (77.2) | 0.62 |
| Female | 67 (21.2) | 74 (22.8) | |
| Height () | 166.34 + 7.14 | 166.04 + 7.37 | 0.60 |
| Weight () | 66.56 ± 8.89 | 64.82 ± 9.53 | 0.02 |
| Pulse () | 74.6 ± 11.93 | 75.56 ± 11.92 | 0.31 |
| Breath () | 19.52 ± 2.03 | 19.41 ± 1.69 | 0.46 |
| Heart rate () | 74.71 ± 12.01 | 75.75 ± 12.29 | 0.28 |
| SBP () | 129.17 ± 19.29 | 130.30 ± 22.00 | 0.49 |
| DBP () | 77.21 ± 11.44 | 77.89 ± 12.58 | 0.47 |
| Combined disease | |||
| Dyslipidemia | 96 (30.4) | 91 (28.1) | 0.52 |
| Hypertension | 182 (57.6) | 179 (55.2) | 0.55 |
| Diabetes | 72 (22.8) | 60 (18.5) | 0.18 |
| Stroke | 16 (5.1) | 13 (4.0) | 0.52 |
| Heart failure | 10 (3.2) | 12 (3.7) | 0.71 |
| Gastrointestinal disorder |
31 (9.8) | 26 (8.0) | 0.43 |
| Arrhythmia | 18 (5.7) | 18 (5.6) | 0.94 |
| Medical history | |||
| Smoking | 159 (50.3) | 165 (50.9) | 0.88 |
| Drinking | 50 (15.8) | 52 (16.0) | 0.94 |
| Family history of CVD | 41 (13.0) | 49 (15.1) | 0.43 |
| Allergy | 31 (9.8) | 30 (9.3) | 0.81 |
| Clinical classification of CHD | |||
| Unstable angina | 168 (53.2) | 193 (59.6) | 0.10 |
| Ml | 148 (46.8) | 131 (40.4) | |
| Cardiac functions | |||
| I | 117 (37.0) | 122 (37.7) | |
| II | 157 (49.7) | 166 (51.2) | 0.70 |
| III | 42 (13.3) | 36 (11.1) |
CHD: coronary heart disease, CVD: cardiovascular disease, DBP: diastolic blood pressure, MI: myocardial infarction, and SBP: systolic blood pressure.